Publication | Closed Access

Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients

UrologyModerate Dose EscalationRadiation TherapyHigh-risk Prostate CancerMedicineBrachytherapyProstatic DiseaseFirst 100OncologyRadiation Oncology